Replies to post #446767 on Anavex Life Sciences Corp (AVXL)

[xodcode]

I believe this new patent is worth $7 to $10 billion for A2-73 ( Blarcamazine ) imo.

Let's hope so! Firstly, let's get A2-73 approval for RETT which will set the stage for those HUGE revenues. As some have pointed out here, the bar for RETT approval is extremely low, so Blarcamesine, which is superior to the existing approved competitor, will be approved, hopefully sooner than many here anticipate.

WGT!

[mike_dotcom]

Looks like the market is saying it's worthless.